The phase 3 results of BioNTech and Pfizer’s COVID-19 vaccine candidate study spells good news for live music, according to Live Nation CEO Michael Rapino.
Live Nation CEO Predicts “Shows at Scale” for Summer 2021
read more
The phase 3 results of BioNTech and Pfizer’s COVID-19 vaccine candidate study spells good news for live music, according to Live Nation CEO Michael Rapino.
With a vaccine on the horizon, both Live Nation and CTS Eventim’s stock prices reached their highest point since February.